Status:
ENROLLING_BY_INVITATION
Gamma tACS in Attention-Deficit/Hyperactivity Disorder
Lead Sponsor:
Medipol University
Conditions:
Attention Deficit Disorder With Hyperactivity (ADHD)
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder characterized by symptoms of inattention, impulsivity, and hyperactivity. These symptoms are often associated wi...
Eligibility Criteria
Inclusion
- Being between 18 and 40 years of age
- Receiving an ADHD diagnosis
- Scoring above 25 on the Montreal Cognitive Assessment (MoCA)
- Being right-handed
Exclusion
- Use of medications with sedative or stimulant effects
- Presence of metal brain implants or a pacemaker
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2027
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07145593
Start Date
October 1 2025
End Date
December 30 2027
Last Update
August 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medipol University Istanbul
Istanbul, Turkey (Türkiye)